For those of you interested, Bloomberg is showing consensus broker NPAT forecasts for FY2018 as $1,721M, well above guidance.
The brokers have raised the bar for NPAT expectations, I guess this is the price you pay for having a high PE and the reputation as the glamour stock of the ASX.
Even if CSL meets its own guidance the market won’t be happy.
Sigh….
No pressure CSL, just got to deliver (and then some)
- Forums
- ASX - By Stock
- CSL
- Broker Consensus NPAT Forecasts
Broker Consensus NPAT Forecasts
Featured News
Add CSL (ASX) to my watchlist
(20min delay)
|
|||||
Last
$277.01 |
Change
-7.040(2.48%) |
Mkt cap ! $134.1B |
Open | High | Low | Value | Volume |
$280.67 | $281.07 | $275.01 | $254.8M | 915.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
13 | 1140 | $277.00 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$277.08 | 312 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 465 | 277.000 |
2 | 183 | 276.500 |
1 | 15 | 276.450 |
1 | 84 | 276.150 |
5 | 168 | 276.000 |
Price($) | Vol. | No. |
---|---|---|
277.490 | 340 | 1 |
277.500 | 500 | 1 |
277.570 | 6 | 1 |
277.850 | 200 | 1 |
278.000 | 50 | 1 |
Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
Featured News
CSL (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online